First Clinical Laparoscopic Procedure Using Teleflex’s New, Less Invasive Percuvance™ Percutaneous Surgical System Perfor...
March 16 2015 - 7:00AM
Business Wire
FDA-cleared system for percutaneous surgery
offers the strength and functionality of a traditional 5 mm
minimally invasive tool but requires fewer trocars and potentially
causes less trauma
Percutaneous insertions mean no trocars are
required for initial access
Compared to traditional laparoscopic surgery,
percutaneous surgery can be even less invasive
Patients expected to heal with minimal
scarring
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, has announced today
that its new Percuvance™ Percutaneous Surgical System, which
provides performance similar to larger tools commonly used in
minimally invasive laparoscopic surgeries, was percutaneously
inserted into a human for the first time in a procedure at
Cleveland Clinic to evaluate the surgical tool.
The Percuvance System has recently received FDA clearance and CE
Mark approval and represents a significant advance in minimally
invasive surgery (MIS). The basis of the system is a less than 3 mm
diameter shaft that, when connected to an introducer tool tip, can
be inserted percutaneously through the skin. The introducer tool
tip can then be exchanged outside the body for a wide variety of 5
mm interchangeable surgical tool tips. The shaft is sufficiently
strong to hold structures, and surgeons can use its interchangeable
tool tips to grasp, cut and manipulate tissue.
In addition, procedures using the Percuvance™ System require
fewer trocars and cause less trauma for the patient.
“The first human procedures with the Percuvance™ System are a
major milestone in our strategy of developing platform technologies
that will broaden Teleflex’s portfolio with novel products that
provide clinical efficacy, enhance patients’ experiences and lower
the overall cost of care,” says John Tushar, President and General
Manager of Teleflex Surgical. “We believe our system has the
potential to transform the standard of care from traditional
laparoscopy to percutaneous surgery.”
Percutaneous Surgery: A simple stepping stone to even less
invasive minimally invasive surgery (MIS)
The Company’s optimism is grounded in two facts:
1. Traditional laparoscopic surgery accounts
for approximately 94 percent of all nonrobotic laparoscopic
surgical procedures, and 2.9 million laparoscopic procedures are
performed each year in the US.1
2. The transition to even less invasive MIS
has been slowed by barriers to adoption. Percutaneous surgery
eliminates these barriers.
According to surgeons interviewed during the product's
development, the Percuvance™ System has a short learning curve. It
requires few adjustments to surgeons’ current techniques as well as
much smaller incisions. Plus, the system does not have the costs
associated with capital, service and fully disposable
technologies.
About the Percuvance™ System
Teleflex’s Percuvance™ Percutaneous Surgical System is intended
to manipulate tissue. It includes components that introduce a
variety of instrument configurations into the abdominal cavity and
requires a smaller incision site than traditional laparoscopic
surgery. It offers a reusable handle that is compatible with
interchangeable instrument tips, which include graspers, scissors
and dissectors. Unlike other laparoscopic devices, the Percuvance™
System affords a percutaneous insertion into the patient without
the use of a trocar. It is indicated for the means to penetrate
soft tissue to access certain areas of the abdomen and used to
grasp, hold and manipulate tissue during laparoscopic surgery. The
Percuvance™ System will become widely commercially available in
2016.
Click here for more information
Teleflex Portfolio of Percutaneous Solutions
The Percuvance™ System complements another key product, MiniLap®
Percutaneous Surgical System, in Teleflex’s growing portfolio of
innovative yet practical solutions for percutaneous surgery. The
MiniLap® System provides delivery and function through an
integrated, disposable 2.3 mm device. Like the Percuvance™ System,
the MiniLap® System does not require a trocar and makes minimally
invasive laparoscopic procedures less invasive.
Initially, both the Percuvance™ and MiniLap® Systems will play
supporting roles in common, less complex procedures in general
surgery (e.g., lap cholecystectomies or appendectomies) and
gynecological surgery. As they gain experience, surgeons also may
find these devices valuable in more complex abdominal procedures.
Teleflex expects to add more tools to the next generation
Percuvance™ System and envisions it having an increasingly
important role in a wide range of common and complex
procedures.
“Teleflex Percutaneous Solutions comprise an innovative and
unparalleled portfolio of devices to perform percutaneous surgery,”
commented Benson Smith, Chairman, President and Chief Executive
Officer of Teleflex. “We believe they fill an important clinical
and economic need in the surgical field and expect they will
contribute to our growth.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Wayne, PA, Teleflex employs approximately 11,700
people and serves healthcare providers worldwide.
Additional information about Teleflex can be obtained from the
company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex®, Percuvance™ and MiniLap® are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates. © 2015
Teleflex Incorporated. All rights reserved. MC-001051
1 Source: Millennium Research Group, Inc, RPUS30LA13
Teleflex Contact:Teleflex IncorporatedJake Elguicze,
610-948-2836Jake.elguicze@teleflex.comorMedia Contact:Sam
Brown Inc.Mariesa Kemble,
608-850-4745mariesakemble@sambrown.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024